Cargando…
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765759/ https://www.ncbi.nlm.nih.gov/pubmed/35063123 http://dx.doi.org/10.1016/S0140-6736(22)00090-3 |
_version_ | 1784634381875281920 |
---|---|
author | Kuhlmann, Constanze Mayer, Carla Konstanze Claassen, Mathilda Maponga, Tongai Burgers, Wendy A Keeton, Roanne Riou, Catherine Sutherland, Andrew D Suliman, Tasnim Shaw, Megan L Preiser, Wolfgang |
author_facet | Kuhlmann, Constanze Mayer, Carla Konstanze Claassen, Mathilda Maponga, Tongai Burgers, Wendy A Keeton, Roanne Riou, Catherine Sutherland, Andrew D Suliman, Tasnim Shaw, Megan L Preiser, Wolfgang |
author_sort | Kuhlmann, Constanze |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8765759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87657592022-01-19 Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose Kuhlmann, Constanze Mayer, Carla Konstanze Claassen, Mathilda Maponga, Tongai Burgers, Wendy A Keeton, Roanne Riou, Catherine Sutherland, Andrew D Suliman, Tasnim Shaw, Megan L Preiser, Wolfgang Lancet Correspondence Elsevier Ltd. 2022 2022-01-18 /pmc/articles/PMC8765759/ /pubmed/35063123 http://dx.doi.org/10.1016/S0140-6736(22)00090-3 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Kuhlmann, Constanze Mayer, Carla Konstanze Claassen, Mathilda Maponga, Tongai Burgers, Wendy A Keeton, Roanne Riou, Catherine Sutherland, Andrew D Suliman, Tasnim Shaw, Megan L Preiser, Wolfgang Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title | Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title_full | Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title_fullStr | Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title_full_unstemmed | Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title_short | Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose |
title_sort | breakthrough infections with sars-cov-2 omicron despite mrna vaccine booster dose |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765759/ https://www.ncbi.nlm.nih.gov/pubmed/35063123 http://dx.doi.org/10.1016/S0140-6736(22)00090-3 |
work_keys_str_mv | AT kuhlmannconstanze breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT mayercarlakonstanze breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT claassenmathilda breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT mapongatongai breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT burgerswendya breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT keetonroanne breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT rioucatherine breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT sutherlandandrewd breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT sulimantasnim breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT shawmeganl breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose AT preiserwolfgang breakthroughinfectionswithsarscov2omicrondespitemrnavaccineboosterdose |